Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab

NCT06272695 is registered in ClinicalTrials.gov with REMD Biotherapeutics, Inc. as lead sponsor.

NCT NCT06272695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06272695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab
Lead sponsor
REMD Biotherapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 15, 2024
Completion date
February 1, 2025
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus